Biologics Safety Testing Market – Trends Forecast Till 2028

Biologics Safety Testing Market, By Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products), Test Type (Endotoxin, Myoplasm, Sterility Test) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: June, 2021

Base Year Estimate: 2020

Report ID: D-PH-BSTM-221

Format:  

Number of Pages: 423

Domain: Pharmaceutical

Biologics Safety Testing Market – Trends Forecast Till 2028

Biologics Safety Testing Market, By Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products), Test Type (Endotoxin, Myoplasm, Sterility Test) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Global Biologics Safety Testing market is anticipated to reach USD 3.5 billion in 2021 growing at a CAGR of 12.5% during the forecasting period, 2021-2028.

A biologic drug is produced by a living organism or is a component of it. Biologic safety testing are conducted on drugs, therapeutics, stem or tissue cell and other derived products. These tests are performed so as to ensure that the products are contamination free. There are multiple types of biologics like vaccine, blood, blood components, cells, allergens, genes, tissues, and recombinant proteins.

Due to an increased RnD in biopharmaceutical sector along with raising concerns over cell contamination and growth of the market of biosimilar and biologics are some of the factors that have supported long-term expansion for Biologics Safety Testing industry.

Biologics Safety Testing Market Report

Global Biologics Safety Testing market is segmented into Product & Service, Application, Test Type and, geography.

Product & Service segment is segmented into Consumables, Instrument, and Services

Application segment is segmented into Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products

Test Type segment is segmented into Endotoxin, Myoplasm, and Sterility Test

Geographically, global Biologics Safety Testing market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Key players in global Biologics Safety Testing market are Maravai Lifesciences (US), Associates of Cape Cod, Inc. (US), bioMérieux SA (France), Sartorius AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Nelson Laboratories, LLC (US), Bio-Rad Laboratories, Inc. (US) and QIAGEN (Germany), Agilent Technologies, Inc. (US), Pacific BioLabs (US), Microcoat Biotechnologie GmbH (Germany), PromoCell GmbH (Germany), FUJIFILM Wako Pure Chemical Corporation (Japan), and Almac Group (UK). Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg) among others.

Available Customizations

In addition to the market data for Biologics Safety Testing market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, conference like Jefferies conference)—to identify and collect information useful for this study of the Biologics Safety Testing market. The purpose of secondary research was to identify and collection of extensive, technical, market-oriented, and commercial study the global Biologics Safety Testing market. Through secondary the market is classified and segmented as per of industry trend, development, regional market. Product and technology development.

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the Biologics Safety Testing market.

Primary Respondent breakdown is given below:

Biologics Safety Testing Market Primary Respondents

 

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validating the total revenue of the Biologics Safety Testing market. This approach has also been used to derive the market for segmentation and sub-segmentation.

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data we contact primary respondent in order to gain 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Biologics Safety Testing market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 3.5 billion

Growth Rate

CAGR of 12.5% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Product & Service, Application, Test Type and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Maravai Lifesciences (US), Associates of Cape Cod, Inc. (US), bioMérieux SA (France), Sartorius AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Nelson Laboratories, LLC (US), Bio-Rad Laboratories, Inc. (US) and QIAGEN (Germany), Agilent Technologies, Inc. (US), Pacific BioLabs (US), Microcoat Biotechnologie GmbH (Germany), PromoCell GmbH (Germany), FUJIFILM Wako Pure Chemical Corporation (Japan), and Almac Group (UK). Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg)

Available Customization

In addition to the market data for Biologics Safety Testing market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.